Partner Content Partner Content Speaker interview MRC Harwell Institute ahead of SMi’s 3D Ce... Speaker interview MRC Harwell Institute
Partner Content Partner Content Interview Released Stefan Przyborski, Chairman for SMi’s 3D ... Interview with Stefan Przyborski
Partner Content Partner Content SMi’s 3D Cell Culture announces key industry speakers and ag... SMi's 3d Cell Culture agenda released
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
